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The Magazine Wharf area, Freetown, Sierra Leone was 
a focus of ongoing Ebola virus transmission from late 
June 2015. Viral genomes linked to this area contain 
a series of 13 T to C substitutions in a 150 base pair 
intergenic region downstream of viral protein 40 open 
reading frame, similar to the Ebolavirus/H.sapiens-
wt/SLE/2014/Makona-J0169 strain (J0169) detected in 
the same town in November 2014. This suggests that 
recently circulating viruses from Freetown descend 
from a J0169-like virus.
In Sierra Leone, two new Ebola virus (EBOV) cases 
were reported from the densely populated Magazine 
Wharf area of Freetown in the Western Area Urban dis-
trict after a period of two weeks in June 2015 with no 
cases in the district. The Magazine Wharf area was 
subsequently a focus of transmission for several weeks 
(http://apps.who.int/ebola/current-situation/ebola-
situation-report-15-july-2015) up to 12 August 2015 
(http://apps.who.int/ebola/current-situation/ebola-
situation-report-12-august-2015), after which no new 
cases were reported from the area (http://apps.who.
int/ebola/current-situation/ebola-situation-report-
30-september-2015). In this study, the whole genomes 
of viruses from patient samples, originating from the 
Western Area Urban district and other districts of the 
country (i.e. Kenema, Kono, and Tonkolili) between 
January and July 2015 are sequenced. Genomes derived 
from samples collected from 30 June onwards in the 
Western Area Urban district have a particular anomaly 
consisting of a series of 13 T to C substitutions in a 150 
bp intergenic region downstream of the viral protein 40 
(VP40) open reading frame (ORF). This anomaly is also 
present in a viral strain, the Ebolavirus/H.sapiens-wt/
SLE/2014/Makona-J0169 (J0169), which was detected 
in Freetown in November 2014. The finding suggests 
that viruses retrieved in June and July 2015 from the 
Western Area Urban district are direct descendants of 
a J0169-like virus. Near real time application of whole 
EBOV genome sequencing and the identification of lin-
eage signatures can be used to monitor the ongoing 
outbreak and test whether newly infected patients are 
part of an identified transmission chain.
Ebola virus disease epidemic in West Africa
An epidemic of EBOV (a negative-sense RNA virus, 
family Filoviridae) disease has been ongoing in West 
Africa since December 2013 affecting mainly Guinea, 
Liberia and Sierra Leone [1]. As of 9 September 2015, 
the cumulative number of suspect, probable and con-
firmed cases stands at 28,183, including 11,306 deaths 
(http://apps.who.int/ebola/current-situation/ebola-sit-
uation-report-9-september-2015). EBOV cases continue 
to be detected and shifts in foci of transmission are 
observed. One of the pillars in the emergency response 
to the epidemic in the area has been the deployment 
of temporary (mobile) laboratories by the international 
community in collaboration with local authorities, 
among which the Dutch Mobile Laboratories (http://
dutchebolalabs.nl/rappor t-implementatie-dutch-
mobile-labs-in-sierra-leone-en-liberia/). These labo-
ratories provide rapid testing capacity for EBOV and 
malaria in support of clinical triage of (suspected) 
patients. In addition, the international community 
is currently working together in sequencing EBOV 
genomes in order to study EBOV evolution [2-7].
Sampling and whole genome sequencing
A total of 49 samples of EBOV positive patients who 
had been tested by Dutch Mobile Laboratories (Table) 
located in the Western Area Urban and Kono districts 
were included in the study. The samples were collected 
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Figure
A) Median-joining haplotype network constructed from an alignment of 563 Ebola virus sequences derived from clinical 
samples and B) alignment of a sequence region where four Ebola virus strains present a genotypical anomaly, Sierra Leone, 
2015
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GP: glycoprotein; L: RNA-dependent RNA polymerase L; NP: nucleoprotein; VP: virus protein; WUR: Western Area Urban district.
A: The 563 Ebola virus isolates’ sequences correspond to nucleotides 148–18,629 of Zaire ebolavirus isolate H.sapiens-wt/SLE/2015/
Makona-Goderich1 (GenBank accession number: KT345616). The median haplotype network was constructed using PopART version 1.7 
(http://popart.otago.ac.nz). Each vertex represents a sampled viral haplotype. The size of each vertex is relative to the number of sampled 
isolates. Coloured vertices indicate determined viral genomes from Western Area Urban (red), Kono (green), Tonkolili (blue), and Kenema 
(purple) districts. The larger font numbers depicted in red represent viral genomes derived from Freetown patients’ samples retrieved in 
June and July 2015 (two of them linked to Magazine Wharf area) with a genotypic anomaly consisting of a series of 13 T to C mutations in a 
150 bp long sequence, which is located in an intergenic region downstream of the VP40 open reading frame. Hatch marks indicate single 
nucleotide mutations alongside each edge. The node labelled 24592 contains sequences 24592 and 24601; node 25103 contains 25083 and 
25103; node 14163 contains 14163 and 14366; node 24552 contains 24552 and 24581; node 24854 contains 24854, 24853, 24605, 24669, 
24677, 24604, and 24758; node 24825 contains 24825 and 24611; node 24818 contains 24818, 24553, and 24573.
B: Genotypic anomaly in four Ebola virus strains from Freetown, Western Area Urban district, consisting of a series of 13 T to C mutations in a 
150 bp long sequence located in an intergenic region downstream of the VP40 open reading frame (genome positions: 5,510–5,633). Three 
of the strains, which are depicted as DML14077, DML14163, and DML14366 on the alignment were characterised in June and July 2015. 
These are respectively EBOV_DML14077_SLe_WesternUrban_20150630 (GenBank accession number: KT357860), EBOV_DML14163_SLe_
WesternUrban_20150703 (GenBank accession number: KT357858), and EBOV_DML14366_SLe_WesternUrban_20150711 (GenBank accession 
number: KT357859). The fourth strain, which is shown as J0169 is Ebolavirus/H.sapiens-wt/SLE/2014/Makona-J0169 (GenBank accession 
number: KP759706) and was characterised in November 2014. The sequences of the four strains are compared with the reference Zaire 
ebolavirus isolate H.sapiens-wt/GIN/2014/Makona-Gueckedou-C05, complete genome (GenBank accession number: KJ660348). The Ebola 
virus genome organisation is shown for reference.
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Specimen ID Specimen type Country Districta Date of specimen collection Accession number
12033 Blood Sierra Leone Western_Urban 19–02–2015 KT357813
12051 Blood Sierra Leone Western_Urban 21–02–2015 KT357814
12116 Blood Sierra Leone Western_Urban 26–02–2015 KT357815
12117 Blood Sierra Leone Western_Urban 26–02–2015 KT357816
12120 Blood Sierra Leone Western_Urban 27–02–2015 KT357817
12137 Blood Sierra Leone Western_Urban 28–02–2015 KT357819
12194 Blood Sierra Leone Western_Urban 04–03–2015 KT357818
12239 Swab Sierra Leone Western_Urban 07–03–2015 KT357820
12260 Blood Sierra Leone Western_Urban 09–03–2015 KT357821
12268 Blood Sierra Leone Western_Urban 10–03–2015 KT357822
12458 Blood Sierra Leone Western_Urban 28–03–2015 KT357823
12485b Swab Sierra Leone Western_Urban 31–03–2015 KT357824
24502b Blood Sierra Leone Kono 13–01–2015 KT357825
24504 Blood Sierra Leone Kono 13–01–2015 KT357826
24506 Blood Sierra Leone Kono 14–01–2015 KT357827
24511 Blood Sierra Leone Kono 14–01–2015 KT357828
24552 Blood Sierra Leone Kono 17–01–2015 KT357829
24553 Blood Sierra Leone Kono 17–01–2015 KT357830
24573 Swab Sierra Leone Kono 18–01–2015 KT357831
24581 Swab Sierra Leone Kono 19–01–2015 KT357832
24592* Swab Sierra Leone Kono 20–01–2015 KT357833
24601* Blood Sierra Leone Kono 20–01–2015 KT357834
24604 Blood Sierra Leone Kono 20–01–2015 KT357835
24605 Blood Sierra Leone Kono 20–01–2015 KT357836
24606 Blood Sierra Leone Kono 20–01–2015 KT357837
24608 Blood Sierra Leone Kono 20–01–2015 KT357838
24611 Swab Sierra Leone Kono 21–01–2015 KT357839
24620b Blood Sierra Leone Kono 21–01–2015 KT357840
24669 Blood Sierra Leone Kono 25–01–2015 KT357841
24677 Swab Sierra Leone Kono 25–01–2015 KT357842
24683** Blood Sierra Leone Kono 26–01–2015 KT357843
24706 Blood Sierra Leone Kono 28–01–2015 KT357844
24708**c Blood Sierra Leone Kono 28–01–2015 KT357845
24720b Blood Sierra Leone Kono 29–01–2015 KT357846
24758 Blood Sierra Leone Kono 30–01–2015 KT357847
24818 Swab Sierra Leone Kono 03–02–2015 KT357848
24825 Blood Sierra Leone Tonkolili 04–02–2015 KT357849
24853 Blood Sierra Leone Kono 06–02–2015 KT357850
24854 Blood Sierra Leone Kono 06–02–2015 KT357851
25083*** Blood Sierra Leone Kono 18–02–2015 KT357852
25103*** Swab Sierra Leone Kono 19–02–2015 KT357853
25123b Swab Sierra Leone Kenema 18–02–2015 KT357854
25180**** Blood Sierra Leone Kono 23–02–2015 KT357855
25344**** Blood Sierra Leone Kono 06–03–2015 KT357856
25411b Blood Sierra Leone Kono 10–03–2015 KT357857
13828 Blood Sierra Leone Western_Urban 22–06–2015 Not applicable
14077 Blood Sierra Leone Western_Urban 30–06–2015 KT357860
14163 Blood Sierra Leone Western_Urban 03–07–2015 KT357858
14366 Swab Sierra Leone Western_Urban 11–07–2015 KT357859
Table
Characteristics of Ebola virus positive specimens, which were subjected to whole genome sequencing, Sierra Leone, 
January–July 2015 (n=49)
ID: identity; Western_Urban: Western Area Urban district.
In the column with specimen IDs, entries with the same number of asterisks indicate specimens derived from the same patient.
a District of patient residence.
b Less reliable consensus sequence due to low coverage regions.
c Not shown in Figure, unreliable consensus sequence due to low coverage regions.
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from patients residing in Kenema, Kono, Tonkolili and 
Western Area Urban districts between January and 
July 2015. Nucleic acids were extracted from the sam-
ples using EZ Advanced XL automated RNA extraction 
(Qiagen). Isolated nucleic acids were subjected to 
reverse transcription/polymerase chain reaction (PCR) 
amplification using the Ion AmpliSeq Ebola Panel Assay 
(Thermo Fisher Scientific) and the Ion Torrent sequenc-
ing platform at a local sequencing facility established at 
the Mateneh Ebola Treatment Centre in Makeni, Bombali 
district, Sierra Leone (European Nucleotide Archive 
Study: PRJEB10265). Reads were extracted from unfil-
tered BAM files using CLC Genomics Workbench 7.5.1 
and trimmed based on quality with an ambiguous limit 
of 2 and quality limit of 0.05. Reads longer than 1,000 
nucleotides (nt) or shorter than 15 nt were discarded. 
Trimmed reads were mapped to Zaire ebolavirus isolate 
H.sapiens-wt/GIN/2014/Makona-Gueckedou-C05, com-
plete genome (GenBank accession number: KJ660348), 
using CLC Genomics Workbench 7.5.1 map reads to 
reference beta module, with the following parameters: 
no masking, mismatch cost 2, insertion and deletion 
open cost 7, insertion and deletion extend cost 3, 
length fraction 0.95, similarity fraction 0.9. Consensus 
sequences were extracted and regions where depth of 
coverage was less than 2 were called as ‘N’. All gener-
ated genomes were manually inspected for accuracy, 
such as for the presence of intact ORFs and low cover-
age regions for adequate base calling, resulting in 48 
near full-length EBOV genomes (Table).
Detection of evolutionary lineages and 
mutations
A median haplotype network was constructed in 
PopART version 1.7 (http://popart.otago.ac.nz) using 
563 determined EBOV genomes from Sierra Leone, 
including those determined in this study ([3-5,7]; Figure 
A; Table). Accordingly, the 48 determined genome 
sequences appeared to belong to multiple distinct evo-
lutionary lineages. Most viruses from the Western Area 
Urban district grouped together as did viruses from 
Kono.
Viruses EBOV_DML14077_SLe_WesternUrban_20150630, 
EBOV_DML14163 _SLe_WesternUrban_20150703, 
and EBOV_DML14366_SLe_WesternUrban_20150711 
(DML14077, DML14163, DML14366) isolated from patients 
from Freetown at the end of June and July (Table) were 
highly similar to each other and were clearly different 
from viruses isolated in Freetown between January and 
March 2015 (Figure A). Two of these viruses were linked 
to the Magazine Wharf area in Freetown, a hotspot for 
EBOV transmission in June and July 2015.
The DML14077, DML14163, and DML14366 viruses 
were most closely related to Ebolavirus/H.sapiens-wt/
SLE/2014/Makona-J0169 (GenBank accession number: 
KP759706) isolated on 9 November 2014 in Freetown 
(Figure A). The J0169 virus had a striking genotypic 
anomaly containing a series of 13 T to C substitutions 
occurring in a region of 150 bp in length in an intergenic 
region downstream of the viral protein 40 (VP40) ORF. 
This anomaly was also present in DML14077, DML14163 
and DML14366 (Figure B). An excessive accumulation 
of T to C mutations has been previously observed in a 
variety of virus genomes, including negative-sense RNA 
viruses and in EBOV in infected cells in vitro, and are a 
hallmark of host adenosine deaminases acting on RNA 
(ADARs) [8-10]. DML14077, DML14163, and DML14366 
had 19, 17, and 18 additional single nt variants, respec-
tively, compared with the J0169 virus, consistent with 
current estimates of evolutionary rate in the Ebola virus 
outbreak [5], suggesting that DML14077, DML14163 and 
DML14366 are direct descendants from a J0169-like 
virus (Figure A). The same stretch of T to C substitu-
tions was found in a partial genome sequence from 
another patient at the end of June, who was also linked 
to the Magazine Wharf area (DML13828; Table; data 
not shown) and it serves as a lineage signature allow-
ing identification and tracking of transmission chains.
Discussion and conclusions
At present only a handful of Ebola virus genomes 
sequenced from the current outbreak contain stretches 
of T to C mutations, and these can be found at differ-
ent locations in the genome [5,7]. All shared nt vari-
ants, such as the conserved T to C mutations observed 
between J0169 [7] and the three viral genomes newly 
characterised in this study, are unlikely the source of 
recurrent induced mutations in individual patients. 
Rather, the T to C substitutions could have been fixed 
in viral lineages in the past and these lineages may be 
capable of efficient human-to-human transmission. 
This would explain how a J0169-like virus with a char-
acteristic series of T to C mutations could have further 
spread in the Magazine Wharf area of Freetown.
It is unlikely that the T to C mutation stretch observed 
in the J0169-like viruses had a fitness advantage over 
other spreading EBOV lineages as in the ca 6–7 months 
of transmission between the first identification of this 
virus lineage (November 2014) and the present, this 
EBOV lineage did not become dominant over others. 
The J0169-like virus lineage seemingly lingered on at 
sufficiently low prevalence that it was not captured in 
genomic surveillance until now. This is not surprising 
given that the amount of whole genome sequences 
available is only a fraction of the 28,183 confirmed, 
probable and suspected cases (http://apps.who.int/
ebola/current-situation/ebola-situation-report-9-sep-
tember-2015) and whole genome sequencing started 
to build momentum relatively late in the outbreak. 
It shows however, that near real time application of 
whole EBOV genome sequencing and the identification 
of lineage signatures can be used to monitor the ongo-
ing outbreak and test whether newly infected patients 
are part of an existing known transmission chain in the 
area.
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